Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Response to Aviv et al

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Whole-Exome Sequencing of Patients With Recurrent HSV-2 Lymphocytic Mollaret Meningitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Comprehensive Physiological Modeling Provides Novel Insights Into Heart Failure With Preserved Ejection Fraction Physiology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Is oropharyngeal sampling a reliable test to detect SARS-CoV-2?

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Long-term prognosis following hospitalization for acute myocarditis - a matched nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Routine monitoring of parvovirus B19 (B19V) the first 6 months posttransplantation was performed in 241 seronegative solid organ transplant (SOT) recipients. Incidence rates during the first month and the second to sixth months posttransplantation were 1.2 (95% confidence interval [CI], .33-3.2) and 0.21 (95% CI, .06-.57) per 100 recipients per month, respectively. Of the 6 SOT recipients with positive B19V polymerase chain reaction, 3 (50%) were admitted to hospital and 2 (33%) were treated with intravenous immunoglobulin. Thus, routine monitoring of B19V in seronegative SOT recipients may not be necessary. Targeted screening 1 month posttransplantation and screening upon clinical suspicion could be an alternative strategy.

OriginalsprogEngelsk
TidsskriftThe Journal of infectious diseases
Vol/bind224
Udgave nummer5
Sider (fra-til)865-869
Antal sider5
ISSN0022-1899
DOI
StatusUdgivet - 1 sep. 2021

ID: 61834104